Back to News
Market Impact: 0.25
Proteome Sciences Reports Higher H1 2026 Revenue, Narrower Loss; Stock Down
Source: Nasdaq
Corporate EarningsCompany FundamentalsHealthcare & Biotech
Proteome Sciences reported higher revenue and a narrower net loss for the six months ended June 30, 2026. The interim results indicate improving operating performance for the contract research organization, though no specific revenue or loss figures were provided.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.30
Ticker Sentiment
PRM0.55
More News
- Japan’s corporate leaders sound alarm over weak yen — even dollar-earners are voicing concerns
- Fed hikes again - an AI-Picked insurer is still cashing in
- Berkshire May Boost Japan Trading House Holdings, Itochu Says
- Berkshire may boost holdings in Japan’s trading houses- Bloomberg
- The Competition's Response to Tesla Robotaxi Day
- Generac's stock soars more than 30% after Amazon deal cements its status as AI power player